Vesicare
Formulated for overactive bladder syndrome to mitigate urgency symptoms.
- Category
- Bladder Health
- Active ingredient
- Solifenacin
- Supply
- Pharmacy
- Route
- Oral use
- Form
- Film-coated tablet
- Strengths
- 5 · 10mg
Vesicare details
- Condition
- Overactive Bladder
- Therapeutic class
- Antimuscarinic
- Pharmacological class
- Antimuscarinic
- Precautions and warnings
- caution in patients with glaucoma; may impair ability to drive
- Minor side effects
- dry mouth; constipation
- Moderate side effects
- dyspepsia; blurred vision
- Serious side effects
- intestinal obstruction, requires immediate medical attention
- Dosage forms
- Film-coated tablet
- Administration route
- Oral use
- Patient summary
- formulated for overactive bladder syndrome to mitigate urgency symptoms.
- Supply category
- Pharmacist only, dispensed without a prescription
- Manufacturer
- Astellas Pharma
- Onset Time
- 1–2 weeks
- Duration
- 24 hours
- Storage instructions
- Store below 25°C.
- Drug interactions
- ketoconazole; verapamil
- Age restrictions
- Not for children.
- Pregnancy and breastfeeding
- Use with caution during pregnancy.
Contraindications
hypersensitivity to solifenacin; urinary retention; severe gastrointestinal conditions
Mechanism of action
Competitive muscarinic receptor antagonist that inhibits bladder contraction by blocking cholinergic pathways, which helps manage incontinence and increased bladder sensitivity effectively.
Where this medicine is registered
- Singapore
- Hong Kong
- Thailand
- Malaysia
- Philippines
- Indonesia
- Taiwan
- South Korea
- Japan
- Australia
- New Zealand
- UAE
- South Africa
About Vesicare
Vesicare contains Solifenacin, an active ingredient utilised to treat the symptoms of Overactive Bladder. Manufactured by Astellas Pharma, these tablets are available in 5mg and 10mg strengths for daily management. The medication helps manage bladder muscle activity associated with this condition, providing a reliable option for long-term health support.
Buying Vesicare online
Vesicare is registered across 14 markets, including the Philippines, Indonesia and Taiwan, with availability extending to South Korea, Japan and the UAE. While the original brand is well-known, generic Solifenacin, much of which is produced in India, offers a more affordable alternative for those seeking cost-effective treatment. This medication is one of the most ordered for bladder care across the region, providing a convenient access point for expats and those living without easy access to a pharmacy.